Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2016-09-05
2018-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: The primary objective is to determine whether abdominal arterial CT angiography is a feasible technique for diagnosing internal herniation after RYGB surgery. Secondary, it is examined whether arterial angiography of the mesentery is superior over conventional CT examination with oral and IV contrast in the venous phase.
Study design: This study will be a prospective pilot study, in which the outcomes of both the conventional CT examination and abdominal angiogram are compared to the outcome of diagnostic laparoscopy as gold standard.
Study population: Patients will be included who underwent laparoscopic RYGB surgery at least half a year earlier and have persisting abdominal pain. They should be highly suspected for internal herniation by their doctor, based on several characteristics.
Main study parameters/endpoints: Primary study endpoints are the assessments of the arterial abdominal angiogram and mesenteric arterial mapping in relation to the outcome of the diagnostic laparoscopic surgery in 12 subjects.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In this pilot study, study subjects will receive an additional effective radiation dose of about 10 mSv. On average, an acute dose of 10 mSv leads to an additional risk of cancer of about 1 in 1750 (\~1 in 2000 for males, \~1 in 1500 for females) for a 50-year old subject, based on the linear no threshold model. However, when the mesenteric artery mapping proves to be feasible and superior, many unnecessary diagnostic laparoscopic surgeries will be prevented (along with their complications and risks).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Pouch Emptying With MRI After Roux-en-Y Gastric Bypass
NCT06298162
Internal Hernias After Laparoscopic Gastric Bypass
NCT01040364
Extending and Banding the Roux-en-Y Gastric Bypass
NCT05357807
An Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study
NCT02811900
Extended Pouch Roux-en-Y Gastric Bypass Study
NCT02218957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CTA-IH
CT angiography
Patients are subjected to a standard abdominal CT scan and (additional in this study) to abdominal CT angiography (CTA)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT angiography
Patients are subjected to a standard abdominal CT scan and (additional in this study) to abdominal CT angiography (CTA)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient should have abdominal pain, at least three days in a row;
* The patient should be highly suspected for internal herniation by their doctor (based on weight loss, location of pain, intervals between pain, relation to food intake).
Exclusion Criteria
* The patient is incompetent to decide;
* The patient is pregnant or gives breast feeding;
* The patient is in emergency setting and requires imminent surgery;
* The patient has other known abdominal pathology or prior large abdominal surgery;
* The patient has had surgery for internal herniation previously;
* The patient has had earlier surgery involving the RYGB, such as distalisation;
* One or both scans have insufficient scan quality;
* The patient will not be subjected to diagnostic laparoscopic surgery (e.g. pain-free patients);
* The patient has a contra-indication for the administration of oral or IV contrast (Xenetide 300mg/ml).:
* Thyrotoxicose
* Overgevoeligheid/allergisch voor Xenetix of in het verleden een allergische reactie op jodiumhoudend contrast
* Treatment with NSAID's, diuretica or aminoglycosiden that cannot be stopped 24 hours before and after the CT
* Treatment with cisplatina less than six weeks before CT
* M.Kahler or M. Waldenstrom
* Kidneyfunction (GFS) \< 60
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura Deden
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rijnstate hospital
Arnhem, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL52257.091.15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.